Get a glimpse into our company and investor data—powered by the PitchBook Platform
Developer and manufacturer of pharmaceutical products. The company is focused on the development of peptide vaccines, which are innovative immunotherapeutic anti-cancer drugs.
This information is reserved for PitchBook Platform users. To explore Gemvax‘s full profile, request access.
© 2020 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.